Paboriv EL
Paboriv EL Products are primarily used for
Gastroesophageal reflux disease (Acid reflux), Peptic ulcer disease
About Paboriv EL Products
Uses of Paboriv EL Products
Levosulpiride+Esomeprazole is used in the treatment of gastroesophageal reflux disease (acid reflux) and peptic ulcer disease.
Paboriv EL Products side effects
Common
Side Effects of Paboriv EL are Nausea, Vomiting, Diarrhea, Headache, Flatulence, Abdominal pain, Dizziness, Joint pain, Drowsiness, Absence of menstrual periods, Breast enlargement in male, Unusual production of breast milk in women and men, Altered libido.
How Paboriv EL Products work
Levosulpiride + Esomeprazole is a combination of two medicines: Levosulpiride + Esomeprazole1 and Levosulpiride + Esomeprazole2.
Patient Concerns about Paboriv EL Products
Frequently asked questions about Paboriv EL Products
Frequently asked questions about Paboriv EL Products
Q. What are the instructions for storage and disposal of Paboriv EL 75mg/40mg Tablet SR?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Q. What is the best time to take Paboriv EL 75mg/40mg Tablet SR?
Take Paboriv EL 75mg/40mg Tablet SR exactly as directed by your doctor. It is best to take one capsule daily on an empty stomach.
Q. What are the contraindications associated with the use of Paboriv EL 75mg/40mg Tablet SR?
The use of Paboriv EL 75mg/40mg Tablet SR should be avoided in patients with known allergy to any of the components or excipients of this medicine.
Q. Can the use of Paboriv EL 75mg/40mg Tablet SR cause dizziness?
Yes, the use of Paboriv EL 75mg/40mg Tablet SR can cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you feel dizzy or lightheaded, it is better to rest for some time and resume once you feel better.
Q. Does the use of Paboriv EL 75mg/40mg Tablet SR lead to increased risk of fractures?
Several studies in adults suggest that treatment with Paboriv EL 75mg/40mg Tablet SR may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine. The risk of fracture was increased in patients who received high dose. High dose can mean multiple daily doses, and long-term therapy (a year or longer).
Products for Paboriv EL
Paboriv EL 75mg/40mg Tablet SR
strip of 10 tablet sr
MRP
₹187
Not Available